Significantly increased detection rate of drugs of abuse in urine following the introduction of new German driving licence re-granting guidelines

Forensic Science International

Volumn 215, Issue 1-3, 2012, Pages 32-37

  Agius, Ronald ^a   Nadulski, Thomas ^a   Kahl, Hans Gerhard ^a   Dufaux, Bertin ^a  

^a Labor Krone   (Germany)

Author keywords

Abstinence monitoring; Cut offs; Driving licence; Drug testing; New MPA guidelines

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; BENZOYLECGONINE; COCAINE; CODEINE; DIHYDROCODEINE; METHAMPHETAMINE; MORPHINE; TETRAHYDROCANNABINOLIC ACID;

ARTICLE; CONTROLLED STUDY; DRIVER LICENCE; DRUG ABUSE; DRUG SCREENING; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; FALSE POSITIVE RESULT; GAS CHROMATOGRAPHY; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; REFERENCE VALUE; SENSITIVITY ANALYSIS; URINALYSIS;

EID: 84856419459     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2011.10.036     Document Type: Article

References (24)

1. K. Müller, G. Laub, 1st Fit to Drive Congress, Berlin, The Medical Psychological Assessment: An Opportunity for the Individual, Safety for the General Public, 2006. Available at: http://www.fit-to-drive.com/2006/downloads/Mueller_Laub.pdf.
2. B. Krohn, 1st Fit to Drive Congress, Berlin, Courses for the re-establishment of fitness to drive with legal consequences, 2006. Available at: http://www.fit-to-drive.com/2006/downloads/Krohn_Fitness_to_Drive.pdf.
3. Nickel W.-R. Re-granting of Driving Licences and Medico-Psychological Assessment of Drivers in Germany and Selected European Countries. Road Traffic and Drugs 2000, Pompidou Group, Council of Europe, p. 292.
4. Schubert W., Mattern R. Beurteilungskriterien: Urteilsbildung in der Medizinisch-Psychologischen Fahreignungsdiagnostik (German Driving Licence Re-granting Guidelines) 2009, Kirschbaum Verlag Bonn, p. 178.
5. R. Agius, T. Nadulski, C. Moore, Validation of LUCIO®-Direct-ELISA kits for the detection of drugs of abuse in urine: application to the new German driving licence re-granting guidelines, Forensic Sci. Int., doi:10.1016/j.forsciint.2011.10.034.
6. Abraham T.T., Lowe R.H., Pirnay S.O., Darwin W.D., Huestis M.A. Simultaneous GC-EI-MS determination of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol, and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol in human urine following tandem enzyme-alkaline hydrolysis. J. Anal. Toxicol. 2007, 31:477-485.
7. Mule S.J., Casella G.A. Confirmation of marijuana, cocaine, morphine, codeine, amphetamine, methamphetamine, phencyclidine by GC/MS in urine following immunoassay screening. J. Anal. Toxicol. 1988, 12:102-107.
8. European Laboratory Guidelines for Legally Defensible Workplace Drug Testing - 1. Urine Drug Testing 2002, European Workplace Drug Testing Society (EWDTS).
9. Drugs of Abuse Testing Guidelines 2006, Swiss Working Group for Drugs of Abuse Testing Guidelines (AGSA).
10. AS/NZS 4308:2008 - Procedures for Specimen Collection and the Detection and Quantitation of Drugs of Abuse in Urine 2008, Standards Australia.
11. Mandatory Guidelines for Federal Workplace Drug Testing Programs 2008, United States Department of Health and Human Services (HHS).
12. Vandevenne M., Vandenbussche H., Verstraete A. Detection time of drugs of abuse in urine. Acta Clin. Belg. 2000, 55:323-333.
13. Baselt R.C. Disposition of Toxic Drugs and Chemicals in Man 2008, Biomedical Publications, Foster City, CA, pp. 83-85.
14. Smith-Kielland A., Skuterud B., Morland J. Urinary excretion of amphetamine after termination of drug abuse. J. Anal. Toxicol. 1997, 21:325-329.
15. Wingert W.E. Lowering cutoffs for initial and confirmation testing for cocaine and marijuana: large-scale study of effects on the rates of drug-positive results. Clin. Chem. 1997, 43:100-103.
16. B. Madea, B. Brinkmann, Handbuch gerichtliche Medizin, S. Berlin, 2003, p. 958.
17. Lafolie P., Beck O., Blennow G., Boreus L., Borg S., Elwin C.E., Karlsson L., Odelius G., Hjemdahl P. Importance of creatinine analyses of urine when screening for abused drugs. Clin. Chem. 1991, 37:1927-1931.
18. Iten P.X. Fahren unter Drogen- und Medikamenteneinfluss - Forensische Interpretation und Begutachtung 1994, Institut für Rechtsmedizin, Zürich.
19. B. Madea, B. Brinkmann, Handbuch gerichtliche Medizin, S. Berlin, 2003, p. 935.
20. Nadulski T., Agius R., Kahl H.-G., Dufaux B. Das Drogen-Screening in Urin- und Haarproben im Rahmen der MPU Untersuchungsergebnisse nach Anwendung der neuen Grenzwerte (Poster presentation) in DGVP and DGVM Annual Symposium 2010.
21. R. Agius, T. Nadulski, H.G. Kahl, B. Dufaux, Ethyl glucuronide in hair - a highly effective test for the monitoring of alcohol consumption, Forensic Sci. Int., [Epub 2011 Oct 21].
22. Wojcik M.H., Hawthorne J.S. Sensitivity of commercial ethyl glucuronide (ETG) testing in screening for alcohol abstinence. Alcohol. Alcohol. 2007, 42:317-320.
23. Borucki K., Schreiner R., Dierkes J., Jachau K., Krause D., Westphal S., Wurst F.M., Luley C., Schmidt-Gayk H. Detection of recent ethanol intake with new markers: comparison of fatty acid ethyl esters in serum and of ethyl glucuronide and the ratio of 5-hydroxytryptophol to 5-hydroxyindole acetic acid in urine. Alcohol. Clin. Exp. Res. 2005, 29:781-787.
24. Mostert L.J., Agius R. Guidelines for workplace drug testing. Workplace Drug Testing 2011, Pharmaceutical Press, London, (Chapter 11). A. Verstraete (Ed.).